發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

            ______    _____     ______    _____   
    ___    /_   _//  /  ___||  /_   _//  |__  //  
   /   ||   -| ||-  | // __     -| ||-     / //   
  | [] ||   _| ||_  | \\_\ ||   _| ||_    / //__  
   \__ ||  /_____//  \____//   /_____//  /_____|| 
    -|_||  `-----`    `---`    `-----`   `-----`  
     `-`